(BPT) – If you’ve had hives, you know how challenging they can be. But you may not know that there is more than one type of hives, or urticaria, and that treatments are available. A brief episode of ...

If you're being treated for hives, your physician will want to hear what you think about your treatment. Is it working? Are your symptoms improving, staying the same, or getting worse? You may be ...

Sanofi SA ($SNY) announced an update on their ongoing clinical study. Study Overview: Sanofi and Regeneron have ...

In September 2025, the US Food and Drug Administration (FDA) approved Rhapsido ® (remibrutinib), an oral small molecule kinase inhibitor, for the treatment of chronic spontaneous urticaria (CSU) in ...

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...

Patients with CSU have an elevated risk of anxiety and depression, necessitating comprehensive management strategies. Research is focused on identifying biomarkers and clinical characteristics to ...

The FDA has approved Quzyttir for the treatment of acute urticaria in adults and children 6 months of age and older. The Food and Drug Administration (FDA) has approved Quzyttir (cetirizine ...

Hives (urticaria) appear as red, itchy bumps on the skin after exposure to certain foods, heat, or medications. They’re an allergic reaction on your skin that may appear as small ovals or patches ...

If you've ever had an allergic reaction that includes hives-a rash with itchy, raised bumps or welts-then you know how uncomfortable they are. In addition to the intense, sometimes uncontrollable ...

Hives, or urticaria, can occur for many reasons, such as exposure to an allergen or a physical trigger, like pressure from tight clothing. It may also indicate an infection or another underlying ...